SUMMARY1. The mechanism of activation of liver phosphorylase after splanchnic nerve stimulation has been investigated in rabbits and compared with the effects of intraportal injections of noradrenaline.2. The increase in the activity of liver phosphorylase-a, the active form of this key glycogenolytic enzyme, in response to injections of noradrenaline was blocked by ,f-adrenergic antagonists, but not by a-adrenergic antagonists, suggesting that the effect of noradrenaline is mediated mainly through f-adrenoceptors in vivo. In contrast, the increase in phosphorylase activity in response to stimulation of the peripheral end of the splanchnic nerve was resistant to both a-and f-adrenoceptor blockade.3. When diltiazem and verapamil, selective Ca2+ antagonists that restrict calcium influx across the cell membrane, were infused intraportally, the phosphorylase response to splanchnic nerve stimulation was virtually abolished, while the response to noradrenaline was unaltered.4. Infusion of the prostaglandin-synthesis inhibitor indomethacin at a dose of 3-4 ,sg/min was found to block the activation of liver phosphorylase in response to stimulation of the splanchnic innervation. 5. These results suggest that the mechanism whereby stimulation ofthe sympathetic innervation to the liver leads to activation of phosphorylase is not mediated by either a-or 8f-adrenoceptors, but appears to depend upon prostaglandin formation and influx of Ca2+ ions into the hepatocytes.